RARX
BNP Paribas Financial Markets’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-19,502
| Closed | -$936K | – | 3793 |
|
|
2020
Q1 | $936K | Buy |
19,502
+15,411
| +377% | +$740K | ﹤0.01% | 1461 |
|
|
2019
Q4 | $192K | Sell |
4,091
-912
| -18% | -$42.8K | ﹤0.01% | 2335 |
|
|
2019
Q3 | $118K | Buy |
5,003
+2,901
| +138% | +$68.6K | ﹤0.01% | 2422 |
|
|
2019
Q2 | $63.2K | Sell |
2,102
-1,815
| -46% | -$54.6K | ﹤0.01% | 2669 |
|
|
2019
Q1 | $87.7K | Buy |
+3,917
| New | +$87.7K | ﹤0.01% | 2618 |
|
|
2018
Q4 | – | Sell |
-1,546
| Closed | -$28K | – | 3761 |
|
|
2018
Q3 | $28K | Buy |
1,546
+187
| +14% | +$3.38K | ﹤0.01% | 2616 |
|
|
2018
Q2 | $13.5K | Sell |
1,359
-2,809
| -67% | -$27.9K | ﹤0.01% | 3007 |
|
|
2018
Q1 | $22.1K | Buy |
4,168
+1,649
| +65% | +$8.76K | ﹤0.01% | 3320 |
|
|
2017
Q4 | $21.4K | Buy |
2,519
+1,293
| +105% | +$11K | ﹤0.01% | 3279 |
|
|
2017
Q3 | $17.9K | Sell |
1,226
-63
| -5% | -$920 | ﹤0.01% | 3120 |
|
|
2017
Q2 | $24.2K | Buy |
1,289
+1,219
| +1,741% | +$22.8K | ﹤0.01% | 3031 |
|
|
2017
Q1 | $1.49K | Buy |
+70
| New | +$1.49K | ﹤0.01% | 3044 |
|